<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37087523</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19.</ArticleTitle><Pagination><StartPage>2329</StartPage><MedlinePgn>2329</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2329</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-37470-4</ELocationID><Abstract><AbstractText>Rhinoviruses and allergens, such as house dust mite are major agents responsible for asthma exacerbations. The influence of pre-existing airway inflammation on the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely unknown. We analyse mechanisms of response to viral infection in experimental in vivo rhinovirus infection in healthy controls and patients with asthma, and in in vitro experiments with house dust mite, rhinovirus and SARS-CoV-2 in human primary airway epithelium. Here, we show that rhinovirus infection in patients with asthma leads to an excessive RIG-I inflammasome activation, which diminishes its accessibility for type I/III interferon responses, leading to their early functional impairment, delayed resolution, prolonged viral clearance and unresolved inflammation in vitro and in vivo. Pre-exposure to house dust mite augments this phenomenon by inflammasome priming and auxiliary inhibition of early type I/III interferon responses. Prior infection with rhinovirus followed by SARS-CoV-2 infection augments RIG-I inflammasome activation and epithelial inflammation. Timely inhibition of the epithelial RIG-I inflammasome may lead to more efficient viral clearance and lower the burden of rhinovirus and SARS-CoV-2 infections.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radzikowska</LastName><ForeName>Urszula</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-7341-9764</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13 Str., 15-269, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eljaszewicz</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8980-1474</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13 Str., 15-269, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ge</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0026-8739</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Functional Genomics Center Zurich, ETH Zurich/University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stocker</LastName><ForeName>Nino</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heider</LastName><ForeName>Anja</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3448-4125</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westermann</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2894-6140</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1999-1425</Identifier><AffiliationInfo><Affiliation>Institute of Virology and Immunology (IVI), Laenggassstrasse 122, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Laenggassstrasse 122, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School for Cellular and Biomedical Sciences, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreher</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wawrzyniak</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Research Center, University Children's Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rückert</LastName><ForeName>Beate</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1804-1698</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Coira</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMMA, Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities Madrid, C. de Julian Romea 23, 28003, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities Madrid, Urb. Monteprincipe 28925, Alcorcon, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhakparov</LastName><ForeName>Damir</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mengting</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakiela</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0444-981X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Jagiellonian University Medical College, M. Skawinska 8 Str., 31-066, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanak</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7635-8103</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Jagiellonian University Medical College, M. Skawinska 8 Str., 31-066, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moniuszko</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7183-3120</Identifier><AffiliationInfo><Affiliation>Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13 Str., 15-269, Bialystok, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Allergology and Internal Medicine, Medical University of Bialystok, M. Sklodowskiej-Curie 24A Str., 15-276, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahony</LastName><ForeName>Liam</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4705-3583</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and School of Microbiology, APC Microbiome Ireland, University College Cork, College Rd, T12 E138, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jutel</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Wroclaw Medical University, wyb. Lidwika Pasteura 1 Str, 50-367, Wroclaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ALL-MED Medical Research Institute, Gen. Jozefa Hallera 95 Str., 53-201, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kebadze</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Cale Street, London, SW3 6LY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Imperial College London, School of Medicine, St Mary's Hospital, Praed Street, London, W21NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Guy's Severe Asthma Centre, School of Immunology &amp; Microbial Sciences, King's College London, Strand, London, WC2R 2LS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guy's &amp; St Thomas' NHS Trust, St Thomas' Hospital, Westminster Bridge Rd, London, SE1 7EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Cale Street, London, SW3 6LY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma UK Centre in Allergic Mechanisms of Asthma, Norfolk Place, London, W2 1PG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiel</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5783-0887</Identifier><AffiliationInfo><Affiliation>Institute of Virology and Immunology (IVI), Laenggassstrasse 122, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Center for Infectious Diseases, University of Bern, Hallerstrasse 6, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Sebastian L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0003-3009-9200</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Cale Street, London, SW3 6LY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma UK Centre in Allergic Mechanisms of Asthma, Norfolk Place, London, W2 1PG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imperial College Healthcare HNS Trust, The Bays, S Wharf Rd, London, W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Akdis</LastName><ForeName>Cezmi A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-8020-019X</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sokolowska</LastName><ForeName>Milena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9710-6685</Identifier><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland. milena.sokolowska@siaf.uzh.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christine Kühne - Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos Wolfgang, Switzerland. milena.sokolowska@siaf.uzh.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G1000758</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090103">Antiviral Restriction Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Commun. 2023 Jun 13;14(1):3493. doi: 10.1038/s41467-023-39275-x</RefSource><PMID Version="1">37311773</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090103" MajorTopicYN="Y">Antiviral Restriction Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="Y">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="Y">Inflammasomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="N">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="Y">Rhinovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>CA reports research grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine Kühne-Center for Allergy Research and Education, European Commission’s Horison’s 2020 Framework Programme “Cure”, Novartis Research Institutes, Astrazeneca, SciBase, Stanford University SEAN Parker Asthma and Allergy Center; advisory board of Sanofi/Regeneron, GSK and Novartis, consulting fees from Novartis; Editor-in-Chief Allergy, Co-Chair EAACI Environmental Science in Allergic Diseases and Asthma Guidelines. AE reports National Science Centre Grant No. 2020/37/N/NZ5/04144, National Centre for Research and Development No. STRATEGMED2/269807/14/NCBR/2015, National Centre for Research and Development (POLTUR3/MT-REMOD/2/2019). DJJ reports advisory board and speaker fees from AstraZeneca, GSK and Sanofi and research grants from AstraZeneca. SLJ reports grants/contracts from European Research Council ERC FP7 grant number 233015, Chair from Asthma UK CH11SJ, Medical Research Council Centre grant number G1000758, NIHR Biomedical Research Centre grant number P26095, Predicta FP7 Collaborative Project grant number 260895, NIHR Emeritus NIHR Senior Investigator; consulting fees from Lallemand Pharma, Bioforce, resTORbio, Gerson Lehrman Group, Boehringer Ingelheim, Novartis, Bayer, Myelo Therapeutics GmbH; patents issued/licensed: Wark PA, Johnston SL, Holgate ST, Davies DE. Anti-virus therapy for respiratory diseases. UK patent application No. GB 0405634.7, 12March 2004. Wark PA, Johnston SL, Holgate ST, Davies DE. Interferon-Beta for Anti-Virus Therapy for Respiratory Diseases. International Patent Application No. PCT/GB05/50031, 12 March 2004. Davies DE, Wark PA, Holgate ST, JohnstonSL. Interferon Lambda therapy for the treatment of respiratory disease. UK patent application No. 6779645.9, granted15th August 2012; Participation on a data safety monitory board or advisory board: Enanta Chair of DSMB, Virtus Respiratory Research Board membership. MJ reports RID- European Commission Research Grant, personal fees from Allergopharma, Stallergenes, Regeneron, Pfizer, Chiesi, Allergopharma, Stallergenes Greer, HAL Allergy; membership in safety monitoring board in Allergopharma; EAACI President position; Clinical Investigator Honoraria from GSK, AstraZeneca, Regeneron, Genetech, Takeda, Chiesi, Novartis, Allergopharma, Stallergenes, Allergy Therapeutics, HAL Allergy, ALK Abello, Shire, Celltrion, Verona Pharma. MM reports personal payments from Astra Zeneca, GSK, Berlin-Chemie/Menarini, Lek-AM, Takeda, Celon and support for attending meetings from Astra Zeneca, GSK, Berlin-Biochemie/Menarini. UR reports board secretary position of Working Group of Genomics and Proteomics of the European Academy of Allergy and Clinical Immunology (EAACI). JRC reports Pre-doctoral grant FPI from Universidad CEU San Pablo, Swiss European Mobility Program grant from University of Zurich, EAACI Mid-term Fellowship. M.So reports research grants from Swiss National Science Foundation (nr 310030_189334/1), Novartis Foundation for Medical-Biological Research, GSK, and Stiftung vorm. Buendner Heilstaette Arosa; speaker’s fee from AstraZeneca; voluntary positions in the European Academy of Allergy and Clinical Immunology (EAACI) as Executive Board member and Basic and Clinical Immunology Section Chair. SS reports funding from National Center of Competence in Research (NCCR) on RNA and Disease to VT (https://nccr-rna-and-disease.ch/). VT reports grant from Swiss National Science Foundation (nr 31CA30_196644). All other authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>23</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37087523</ArticleId><ArticleId IdType="pmc">PMC10122208</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-37470-4</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-37470-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat. Rev. Immunol. 2006;6:869–874. doi: 10.1038/nri1958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1958</ArticleId><ArticleId IdType="pubmed">17063187</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Available from: www.ginasthma.org. (2020).</Citation></Reference><Reference><Citation>Papadopoulos NG, et al. Viruses and bacteria in acute asthma exacerbations–a GA(2) LEN-DARE systematic review. Allergy. 2011;66:458–468. doi: 10.1111/j.1398-9995.2010.02505.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2010.02505.x</ArticleId><ArticleId IdType="pmc">PMC7159474</ArticleId><ArticleId IdType="pubmed">21087215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CK, Callaway Z, Gern JE. Viral infections and associated factors that promote acute exacerbations of asthma. Allergy Asthma Immunol. Res. 2018;10:12–17. doi: 10.4168/aair.2018.10.1.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2018.10.1.12</ArticleId><ArticleId IdType="pmc">PMC5705478</ArticleId><ArticleId IdType="pubmed">29178673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiang D, et al. Molecular characterization of a variant rhinovirus from an outbreak associated with uncommonly high mortality. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2007;38:227–237. doi: 10.1016/j.jcv.2006.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.12.016</ArticleId><ArticleId IdType="pubmed">17276135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubner FJ, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J. Allergy Clin. Immunol. 2017;139:501–507. doi: 10.1016/j.jaci.2016.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.03.049</ArticleId><ArticleId IdType="pmc">PMC5104680</ArticleId><ArticleId IdType="pubmed">27312820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Bønnelykke K, Elenius V, Feleszko W. Role of viruses in asthma. Semin. Immunopathol. 2020;42:61–74. doi: 10.1007/s00281-020-00781-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00781-5</ArticleId><ArticleId IdType="pmc">PMC7066101</ArticleId><ArticleId IdType="pubmed">31989228</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze A, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir. Med. 2020;8:1106–1120. doi: 10.1016/S2213-2600(20)30415-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30415-X</ArticleId><ArticleId IdType="pmc">PMC7515601</ArticleId><ArticleId IdType="pubmed">32979987</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom CI, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO clinical characterisation protocol UK. Lancet Respir. Med. 2021;9:699–711. doi: 10.1016/S2213-2600(21)00013-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00013-8</ArticleId><ArticleId IdType="pmc">PMC8241313</ArticleId><ArticleId IdType="pubmed">33676593</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveyard P, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir. Med. 2021;9:909–923. doi: 10.1016/S2213-2600(21)00095-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00095-3</ArticleId><ArticleId IdType="pmc">PMC8016404</ArticleId><ArticleId IdType="pubmed">33812494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J. Allergy Clin. Immunol. 2020;146:327–329.e324. doi: 10.1016/j.jaci.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7423602</ArticleId><ArticleId IdType="pubmed">32522462</ArticleId></ArticleIdList></Reference><Reference><Citation>Skevaki C, et al. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat. Rev. Immunol. 2021;21:202–203. doi: 10.1038/s41577-021-00516-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00516-z</ArticleId><ArticleId IdType="pmc">PMC7901163</ArticleId><ArticleId IdType="pubmed">33623123</ArticleId></ArticleIdList></Reference><Reference><Citation>Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J. Allergy Clin. Immunol. 2020;146:1295–1301. doi: 10.1016/j.jaci.2020.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.09.017</ArticleId><ArticleId IdType="pmc">PMC7834224</ArticleId><ArticleId IdType="pubmed">33002516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J. Allergy Clin. Immunol. Pr. 2022;10:124–133. doi: 10.1016/j.jaip.2021.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.049</ArticleId><ArticleId IdType="pmc">PMC8556867</ArticleId><ArticleId IdType="pubmed">34728408</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. Prevalence and risk of severe disease. Am. J. Respir. Crit. Care Med. 2021;203:893–905. doi: 10.1164/rccm.202008-3266OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202008-3266OC</ArticleId><ArticleId IdType="pmc">PMC8017581</ArticleId><ArticleId IdType="pubmed">33493416</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, A. M. et al. Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases. J. Allergy Clin. Immunol.148, 533–549 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298629</ArticleId><ArticleId IdType="pubmed">33493557</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Quiros M, et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J. allergy Clin. Immunol. 2012;129:1499–1505.e1495. doi: 10.1016/j.jaci.2012.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.03.040</ArticleId><ArticleId IdType="pmc">PMC3792652</ArticleId><ArticleId IdType="pubmed">22560151</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CS, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61:376–382. doi: 10.1136/thx.2005.042523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.042523</ArticleId><ArticleId IdType="pmc">PMC2111190</ArticleId><ArticleId IdType="pubmed">16384881</ArticleId></ArticleIdList></Reference><Reference><Citation>Virchow JC, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. Jama. 2016;315:1715–1725. doi: 10.1001/jama.2016.3964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.3964</ArticleId><ArticleId IdType="pubmed">27115376</ArticleId></ArticleIdList></Reference><Reference><Citation>Balz K, et al. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses. Sci. Rep. 2021;11:4792. doi: 10.1038/s41598-021-84320-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84320-8</ArticleId><ArticleId IdType="pmc">PMC7910599</ArticleId><ArticleId IdType="pubmed">33637823</ArticleId></ArticleIdList></Reference><Reference><Citation>Damialis A, et al. Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe. Proc. Natl. Acad. Sci. USA. 2021;118:e2019034118. doi: 10.1073/pnas.2019034118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2019034118</ArticleId><ArticleId IdType="pmc">PMC7999946</ArticleId><ArticleId IdType="pubmed">33798095</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater L, et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 2010;6:e1001178. doi: 10.1371/journal.ppat.1001178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001178</ArticleId><ArticleId IdType="pmc">PMC2973831</ArticleId><ArticleId IdType="pubmed">21079690</ArticleId></ArticleIdList></Reference><Reference><Citation>Xander N, et al. Rhinovirus-induced SIRT-1 via TLR2 regulates subsequent type I and type III IFN responses in airway epithelial cells. J. Immunol. (Baltim., Md: 1950) 2019;203:2508–2519. doi: 10.4049/jimmunol.1900165.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900165</ArticleId><ArticleId IdType="pmc">PMC6810856</ArticleId><ArticleId IdType="pubmed">31548332</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 2020;20:537–551. doi: 10.1038/s41577-020-0288-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner SM, Wiehler S, Michi AN, Proud D. Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells. Respir. Res. 2019;20:150. doi: 10.1186/s12931-019-1120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1120-0</ArticleId><ArticleId IdType="pmc">PMC6626354</ArticleId><ArticleId IdType="pubmed">31299975</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel DA, et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J. Allergy Clin. Immunol. 2014;134:1402–1412.e1407. doi: 10.1016/j.jaci.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.07.013</ArticleId><ArticleId IdType="pmc">PMC4261010</ArticleId><ArticleId IdType="pubmed">25216987</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards MR, et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 2013;6:797–806. doi: 10.1038/mi.2012.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2012.118</ArticleId><ArticleId IdType="pmc">PMC3684776</ArticleId><ArticleId IdType="pubmed">23212197</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowska M, et al. Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma. J. Allergy Clin. Immunol. 2017;139:1379–1383. doi: 10.1016/j.jaci.2016.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.09.031</ArticleId><ArticleId IdType="pmc">PMC5385283</ArticleId><ArticleId IdType="pubmed">27826094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 2020;11:3810. doi: 10.1038/s41467-020-17665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036–1045 e1039. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278–286. doi: 10.1038/nature10759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10759</ArticleId><ArticleId IdType="pubmed">22258606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu A, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156:1193–1206. doi: 10.1016/j.cell.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4000066</ArticleId><ArticleId IdType="pubmed">24630722</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeck H, et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 2010;11:63–69. doi: 10.1038/ni.1824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1824</ArticleId><ArticleId IdType="pubmed">19915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, et al. Inflammasome activation is required for human rhinovirus-induced airway inflammation in naive and allergen-sensitized mice. Mucosal Immunol. 2019;12:958–968. doi: 10.1038/s41385-019-0172-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-019-0172-2</ArticleId><ArticleId IdType="pmc">PMC6668626</ArticleId><ArticleId IdType="pubmed">31089187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothlichet J, et al. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog. 2013;9:e1003256. doi: 10.1371/journal.ppat.1003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003256</ArticleId><ArticleId IdType="pmc">PMC3623797</ArticleId><ArticleId IdType="pubmed">23592984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010;11:404–410. doi: 10.1038/ni.1861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1861</ArticleId><ArticleId IdType="pmc">PMC2857582</ArticleId><ArticleId IdType="pubmed">20383149</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen IC, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30:556–565. doi: 10.1016/j.immuni.2009.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.02.005</ArticleId><ArticleId IdType="pmc">PMC2803103</ArticleId><ArticleId IdType="pubmed">19362020</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu KL, et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2019;33:8865–8877. doi: 10.1096/fj.201802418R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802418R</ArticleId><ArticleId IdType="pmc">PMC6662968</ArticleId><ArticleId IdType="pubmed">31034780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IY, Moriyama M, Chang MF, Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front. Microbiol. 2019;10:50. doi: 10.3389/fmicb.2019.00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00050</ArticleId><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell GR, To RK, Hanna J, Spector SA. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway. iScience. 2021;24:102295. doi: 10.1016/j.isci.2021.102295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102295</ArticleId><ArticleId IdType="pmc">PMC7939994</ArticleId><ArticleId IdType="pubmed">33718825</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira, C. et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. medRxiv: The preprint server for health sciences10.1101/2021.03.06.21252796 (2021).</Citation></Reference><Reference><Citation>Lupfer C, et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat. Immunol. 2013;14:480–488. doi: 10.1038/ni.2563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2563</ArticleId><ArticleId IdType="pmc">PMC3631456</ArticleId><ArticleId IdType="pubmed">23525089</ArticleId></ArticleIdList></Reference><Reference><Citation>Spel L, Martinon F. Detection of viruses by inflammasomes. Curr. Opin. Virol. 2021;46:59–64. doi: 10.1016/j.coviro.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7959698</ArticleId><ArticleId IdType="pubmed">33176273</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen IC, et al. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. (Baltim., Md: 1950) 2012;188:2884–2893. doi: 10.4049/jimmunol.1102488.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102488</ArticleId><ArticleId IdType="pmc">PMC3294123</ArticleId><ArticleId IdType="pubmed">22323538</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HT, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74:294–307. doi: 10.1111/all.13619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13619</ArticleId><ArticleId IdType="pubmed">30267575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossios C, et al. Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma. J. Allergy Clin. Immunol. 2018;141:560–570. doi: 10.1016/j.jaci.2017.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.02.045</ArticleId><ArticleId IdType="pubmed">28528200</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 2014;190:1373–1382. doi: 10.1164/rccm.201406-1039OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201406-1039OC</ArticleId><ArticleId IdType="pmc">PMC4299647</ArticleId><ArticleId IdType="pubmed">25350863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman ED, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008;31:143–178. doi: 10.1183/09031936.00138707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00138707</ArticleId><ArticleId IdType="pubmed">18166595</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancey SW, et al. Biomarkers for severe eosinophilic asthma. J. Allergy Clin. Immunol. 2017;140:1509–1518. doi: 10.1016/j.jaci.2017.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.10.005</ArticleId><ArticleId IdType="pubmed">29221581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, et al. Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhinovirus. PLoS One. 2015;10:e0118286. doi: 10.1371/journal.pone.0118286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118286</ArticleId><ArticleId IdType="pmc">PMC4338293</ArticleId><ArticleId IdType="pubmed">25706956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rintahaka J, Wiik D, Kovanen PE, Alenius H, Matikainen S. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J. Immunol. (Baltim., Md: 1950) 2008;180:1749–1757. doi: 10.4049/jimmunol.180.3.1749.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.3.1749</ArticleId><ArticleId IdType="pubmed">18209072</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Kar S, van Kuppeveld FJ, Triantafilou M. Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am. J. Respir. Cell Mol. Biol. 2013;49:923–934. doi: 10.1165/rcmb.2013-0032OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0032OC</ArticleId><ArticleId IdType="pubmed">23815151</ArticleId></ArticleIdList></Reference><Reference><Citation>Farne H, et al. In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection. Thorax. 2022;77:929–932. doi: 10.1136/thoraxjnl-2021-217389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217389</ArticleId><ArticleId IdType="pubmed">35790388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzeng TC, et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during In Vivo infection. Cell Rep. 2016;16:571–582. doi: 10.1016/j.celrep.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.06.011</ArticleId><ArticleId IdType="pmc">PMC5384574</ArticleId><ArticleId IdType="pubmed">27346360</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulimood TB, Corden JM, Bryden C, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternata. J. Allergy Clin. Immunol. 2007;120:610–617. doi: 10.1016/j.jaci.2007.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2007.04.045</ArticleId><ArticleId IdType="pubmed">17624415</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt EB, et al. Diesel exhaust particle induction of IL-17A contributes to severe asthma. J. Allergy Clin. Immunol. 2013;132:1194–1204.e1192. doi: 10.1016/j.jaci.2013.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.06.048</ArticleId><ArticleId IdType="pmc">PMC3845500</ArticleId><ArticleId IdType="pubmed">24060272</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182–193.e187. doi: 10.1053/j.gastro.2010.03.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2010.03.057</ArticleId><ArticleId IdType="pmc">PMC4116278</ArticleId><ArticleId IdType="pubmed">20381491</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan H, et al. Transmembrane-bound IL-15-promoted epithelial-mesenchymal transition in renal cancer cells requires the src-dependent Akt/GSK-3β/β-catenin pathway. Neoplasia (N. Y., NY) 2015;17:410–420. doi: 10.1016/j.neo.2015.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2015.04.002</ArticleId><ArticleId IdType="pmc">PMC4468369</ArticleId><ArticleId IdType="pubmed">26025664</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma. Oncotarget. 2016;7:3267–3282. doi: 10.18632/oncotarget.6572.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6572</ArticleId><ArticleId IdType="pmc">PMC4823105</ArticleId><ArticleId IdType="pubmed">26675549</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SJ, Kim HJ, Lee JS, Cho HR, Kwon B. Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation. Mol. Cells. 2012;33:533–537. doi: 10.1007/s10059-012-0077-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10059-012-0077-3</ArticleId><ArticleId IdType="pmc">PMC3887753</ArticleId><ArticleId IdType="pubmed">22526397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann MA, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889–901. doi: 10.1016/S0092-8674(00)80801-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80801-6</ArticleId><ArticleId IdType="pubmed">10399917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mühlebach MD, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature. 2011;480:530–533. doi: 10.1038/nature10639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10639</ArticleId><ArticleId IdType="pmc">PMC3245798</ArticleId><ArticleId IdType="pubmed">22048310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnoni F, et al. CD40 on adult human airway epithelial cells: expression and proinflammatory effects. J. Immunol. 2004;172:3205–3214. doi: 10.4049/jimmunol.172.5.3205.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.5.3205</ArticleId><ArticleId IdType="pubmed">14978128</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger K, Lowder TW, Tucker TA, Schwiebert LM. Epithelial cells as immune effector cells: the role of CD40. Semin. Immunol. 2009;21:289–292. doi: 10.1016/j.smim.2009.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2009.06.002</ArticleId><ArticleId IdType="pmc">PMC2749080</ArticleId><ArticleId IdType="pubmed">19628407</ArticleId></ArticleIdList></Reference><Reference><Citation>Infante M, et al. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. J. Exp. Clin. Cancer Res.: CR. 2019;38:12. doi: 10.1186/s13046-018-1001-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-018-1001-2</ArticleId><ArticleId IdType="pmc">PMC6325760</ArticleId><ArticleId IdType="pubmed">30621730</ArticleId></ArticleIdList></Reference><Reference><Citation>Loser K, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 2006;12:1372–1379. doi: 10.1038/nm1518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1518</ArticleId><ArticleId IdType="pubmed">17143276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitoma H, et al. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. Immunity. 2013;39:123–135. doi: 10.1016/j.immuni.2013.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.07.001</ArticleId><ArticleId IdType="pmc">PMC3756931</ArticleId><ArticleId IdType="pubmed">23871209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Souza N, et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am. J. Physiol. Lung Cell Mol. Physiol. 2004;286:L373–L381. doi: 10.1152/ajplung.00300.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00300.2003</ArticleId><ArticleId IdType="pubmed">14711802</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakiela B, et al. Remodeling of bronchial epithelium caused by asthmatic inflammation affects its response to rhinovirus infection. Sci. Rep. 2021;11:12821. doi: 10.1038/s41598-021-92252-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92252-6</ArticleId><ArticleId IdType="pmc">PMC8211645</ArticleId><ArticleId IdType="pubmed">34140575</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Anton A, et al. Changes in microRNA and mRNA expression with differentiation of human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 2013;49:384–395. doi: 10.1165/rcmb.2012-0368OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2012-0368OC</ArticleId><ArticleId IdType="pmc">PMC3824051</ArticleId><ArticleId IdType="pubmed">23590309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis-Rogers N, Seger J, Adler FR. Human rhinovirus diversity and evolution: how strange the change from major to minor. J. Virol. 2017;91:e01659–16. doi: 10.1128/JVI.01659-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01659-16</ArticleId><ArticleId IdType="pmc">PMC5355621</ArticleId><ArticleId IdType="pubmed">28100614</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Z, Shen X, Feng H, Gao B. IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J. Immunol. (Baltim., Md: 1950) 2000;165:3959–3965. doi: 10.4049/jimmunol.165.7.3959.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.7.3959</ArticleId><ArticleId IdType="pubmed">11034404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Barber KD, et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature. 2014;511:99–103. doi: 10.1038/nature13489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13489</ArticleId><ArticleId IdType="pmc">PMC4809146</ArticleId><ArticleId IdType="pubmed">24990750</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 2006;12:1023–1026. doi: 10.1038/nm1462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1462</ArticleId><ArticleId IdType="pubmed">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A, et al. Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax. 2014;69:240–246. doi: 10.1136/thoraxjnl-2012-202909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-202909</ArticleId><ArticleId IdType="pubmed">24127021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad H, et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009;15:410–416. doi: 10.1038/nm.1946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1946</ArticleId><ArticleId IdType="pmc">PMC2789255</ArticleId><ArticleId IdType="pubmed">19330007</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuijs MJ, et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 2015;349:1106–1110. doi: 10.1126/science.aac6623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac6623</ArticleId><ArticleId IdType="pubmed">26339029</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarshahi H, et al. House dust mite impairs antiviral response in asthma exacerbation models through its effects on TLR3. Allergy. 2018;73:1053–1063. doi: 10.1111/all.13378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13378</ArticleId><ArticleId IdType="pubmed">29319193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloepfer KM, et al. Increased H1N1 infection rate in children with asthma. Am. J. Respir. Crit. Care Med. 2012;185:1275–1279. doi: 10.1164/rccm.201109-1635OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201109-1635OC</ArticleId><ArticleId IdType="pmc">PMC3381233</ArticleId><ArticleId IdType="pubmed">22366048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J-j, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. doi: 10.1111/all.14238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14238</ArticleId><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JM, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J. Allergy Clin. Immunol. 2020;146:790–798. doi: 10.1016/j.jaci.2020.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7428784</ArticleId><ArticleId IdType="pubmed">32810517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom CI, Cullinan P, Wedzicha JA. Asthma phenotypes and COVID-19 risk: a population-based observational study. Am. J. Respir. Crit. Care Med. 2022;205:36–45. doi: 10.1164/rccm.202107-1704OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202107-1704OC</ArticleId><ArticleId IdType="pmc">PMC8865578</ArticleId><ArticleId IdType="pubmed">34669568</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Glass E, et al. Incidence and outcome of coinfections with SARS-CoV-2 and rhinovirus. Viruses. 2021;13:2528. doi: 10.3390/v13122528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122528</ArticleId><ArticleId IdType="pmc">PMC8709236</ArticleId><ArticleId IdType="pubmed">34960797</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderwall ER, et al. Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. Sci. Rep. 2022;12:6972. doi: 10.1038/s41598-022-10763-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10763-2</ArticleId><ArticleId IdType="pmc">PMC9048621</ArticleId><ArticleId IdType="pubmed">35484173</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M, et al. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg. Microbes Infect. 2022;11:412–423. doi: 10.1080/22221751.2021.2021806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2021806</ArticleId><ArticleId IdType="pmc">PMC8803056</ArticleId><ArticleId IdType="pubmed">34931581</ArticleId></ArticleIdList></Reference><Reference><Citation>Dee K, et al. Human rhinovirus infection blocks severe acute respiratory syndrome coronavirus 2 replication within the respiratory epithelium: implications for COVID-19 epidemiology. J. Infect. Dis. 2021;224:31–38. doi: 10.1093/infdis/jiab147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab147</ArticleId><ArticleId IdType="pmc">PMC8083659</ArticleId><ArticleId IdType="pubmed">33754149</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocker, N. et al. Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium. Mucosal Immunology16, 5–16 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9836991</ArticleId><ArticleId IdType="pubmed">36642382</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JR, et al. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Lancet Respir. Med. 2022;10:545–556. doi: 10.1016/S2213-2600(22)00002-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00002-9</ArticleId><ArticleId IdType="pmc">PMC8989397</ArticleId><ArticleId IdType="pubmed">35397798</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829–2845. doi: 10.1111/all.14429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, et al. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 2021;40:e107826. doi: 10.15252/embj.2021107826.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107826</ArticleId><ArticleId IdType="pmc">PMC8209947</ArticleId><ArticleId IdType="pubmed">34101213</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 2021;218:e20201707. doi: 10.1084/jem.20201707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AC, et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Disco. 2021;7:43. doi: 10.1038/s41420-021-00428-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00428-w</ArticleId><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery SA, Sariol A, Perlman S. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Cell Host Microbe. 2021;29:1052–1062. doi: 10.1016/j.chom.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8126603</ArticleId><ArticleId IdType="pubmed">34022154</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalovich D, et al. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients. Nat. Commun. 2019;10:5711. doi: 10.1038/s41467-019-13751-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13751-9</ArticleId><ArticleId IdType="pmc">PMC6911092</ArticleId><ArticleId IdType="pubmed">31836714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawrzyniak P, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J. Allergy Clin. Immunol. 2017;139:93–103. doi: 10.1016/j.jaci.2016.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.03.050</ArticleId><ArticleId IdType="pubmed">27312821</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi Nhu Thao T, et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature. 2020;582:561–565. doi: 10.1038/s41586-020-2294-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2294-9</ArticleId><ArticleId IdType="pubmed">32365353</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel V, Herold J, Schelle B, Siddell SG. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J. Gen. Virol. 2001;82:1273–1281. doi: 10.1099/0022-1317-82-6-1273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-6-1273</ArticleId><ArticleId IdType="pubmed">11369870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowska M, et al. Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J. Immunol. (Baltim., Md: 1950) 2015;194:5472–5487. doi: 10.4049/jimmunol.1401343.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401343</ArticleId><ArticleId IdType="pmc">PMC4433768</ArticleId><ArticleId IdType="pubmed">25917098</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, et al. Bronchial mucosal IFN-alpha/beta and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 2019;143:114–125.e114. doi: 10.1016/j.jaci.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.04.003</ArticleId><ArticleId IdType="pmc">PMC6320262</ArticleId><ArticleId IdType="pubmed">29698627</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaudel C, et al. Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33. J. Allergy Clin. Immunol. (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29331644</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47. doi: 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, G. Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19: Microarray data analysis code. Zenodo10.5281/zenodo.7699035 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10122208</ArticleId><ArticleId IdType="pubmed">37087523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>